Skip to content
BidBenchmark

Contract award

ELUSYS THERAPEUTICS INC

MANUFACTURE AND DELIVERY OF MAB ANTHRAX ANTITOXINS - MODIFICATION P0007 IS TO DEOBLIGATE THE REMAINING FUNDS AND CLOSE THE ORDER.
PIID
HHSO100201300010I
Award key
CONT_IDV_HHSO100201300010I_7505
Recipient UEI
ELP1DCK8L191
Source as of
Aug 6, 2026
Current award value
—3
Obligated to date
$02
Potential with options
$03
Awarding agency
Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response
Place of performance
—
Set-aside
Small Business Set-Aside - Partial
Pricing
FIRM FIXED PRICE
Competition
—5 offers received
Period of performance
Sep 9, 2013 — —
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
P00007Apr 7, 2026CLOSE OUT-$100,000.00—

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.124edb1916585
contractor_idUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.124edb1916585
current_award_valueUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.124edb1916585
naics_codeUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.124edb1916585
potential_award_valueUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.124edb1916585
psc_codeUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.124edb1916585
total_obligatedUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.124edb1916585

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 1 transaction records parsed from USAspending.gov (FY2026_All_Contracts_Full_20260807_2.csv), retrieved Aug 10, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
HHSO100201300010I — ELUSYS THERAPEUTICS INC · BidBenchmark